Literature DB >> 9837974

Soluble LDL minireceptors. Minimal structure requirements for recognition of minor group human rhinovirus.

T C Marlovits1, C Abrahamsberg, D Blaas.   

Abstract

Soluble human low density lipoprotein minireceptors with less than seven ligand binding repeats (as are present in the native membrane receptor) were expressed in Sf9 insect cells with a hexa-His tag fused to the C terminus. The recombinant truncated proteins were affinity purified from the tissue culture supernatants by Ni-NTA column chromatography. Minireceptors with more than two repeats bound to rabbit beta very low density lipoprotein and could thus be further purified by affinity chromatography. Binding and cell protection assays indicated that two ligand binding repeats are sufficient for attachment of minor group human rhinoviruses to immobilized receptors, whereas at least three ligand binding repeats are required to protect HeLa cells against viral infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9837974     DOI: 10.1074/jbc.273.50.33835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Viral evolution toward change in receptor usage: adaptation of a major group human rhinovirus to grow in ICAM-1-negative cells.

Authors:  A Reischl; M Reithmayer; G Winsauer; R Moser; I Gösler; D Blaas
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  A mutation in the first ligand-binding repeat of the human very-low-density lipoprotein receptor results in high-affinity binding of the single V1 module to human rhinovirus 2.

Authors:  Stephane Nizet; Juergen Wruss; Nathalie Landstetter; Luc Snyers; Dieter Blaas
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding.

Authors:  Marketa Vlasak; Merja Roivainen; Manuela Reithmayer; Irene Goesler; Pia Laine; Luc Snyers; Tapani Hovi; Dieter Blaas
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Identification of the human rhinovirus serotype 1A binding site on the murine low-density lipoprotein receptor by using human-mouse receptor chimeras.

Authors:  Barbara Herdy; Luc Snyers; Manuela Reithmayer; Peter Hinterdorfer; Dieter Blaas
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Identification of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen.

Authors:  Roberto Clemente; Eugene Sisman; Pedro Aza-Blanc; Juan C de la Torre
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

8.  Very-low-density lipoprotein receptor fragment shed from HeLa cells inhibits human rhinovirus infection.

Authors:  T C Marlovits; C Abrahamsberg; D Blaas
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Liposomal nanocontainers as models for viral infection: monitoring viral genomic RNA transfer through lipid membranes.

Authors:  Gerhard Bilek; Nena M Matscheko; Angela Pickl-Herk; Victor U Weiss; Xavier Subirats; Ernst Kenndler; Dieter Blaas
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

Review 10.  The Unresolved Role of Interferon-λ in Asthma Bronchiale.

Authors:  Nina Sopel; Andreas Pflaum; Julia Kölle; Susetta Finotto
Journal:  Front Immunol       Date:  2017-08-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.